Coagulation Diagnostic Testing Markets 2013
October 01, 2013 09:40 ET
|
Research and Markets
Dublin, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/mn99vc/coagulation)
has announced the addition of the "Coagulation
Diagnostic Testing Markets"...
Point of Care Diagnostic Testing: World Markets Report 2013
September 30, 2013 10:06 ET
|
Research and Markets
Dublin, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/k9cqwf/point_of_care)
has announced the addition of the "Point
of Care...
Stellar Biotechnologies' Shares Begin Trading on the OTCQB Market
January 15, 2013 13:43 ET
|
stellar biotechnologies.com
PORT HUENEME, CA--(Marketwire - Jan 15, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the world leader in sustainable manufacture of...
CTLM(R), 3D Laser Breast Imaging System, Demonstrates Significant Results When Imaging Dense Breasts
December 11, 2012 10:16 ET
|
Imaging Diagnostic Systems, Inc.
FORT LAUDERDALE, Fla., Dec. 11, 2012 (GLOBE NEWSWIRE) -- Imaging Diagnostic Systems, Inc. (OTC:IMDSD), a pioneer in laser breast imaging, announced today that Clinical Imaging, a leading US based...
Stellar Biotechnologies Files U.S. Patent Application for KLH Manufacturing Innovations
December 04, 2012 08:55 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 4, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable...
Stellar Biotechnologies Announces Filing a US Letters Patent Application
October 04, 2012 15:19 ET
|
stellar biotechnologies.com
PORT HUENEME, CA--(Marketwire - Oct 4, 2012) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is very pleased to announce the...
Zyomyx, Inc. Announces Appointment of Chief Financial Officer
September 24, 2012 08:00 ET
|
Zyomyx, Inc.
FREMONT, Calif., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Zyomyx, Inc., an innovator in the development and commercialization of proprietary diagnostic platforms, has appointed Jennifer McFarlane as Chief...
Labceutics Launches "Labceutics Connect" Platform
June 19, 2012 02:00 ET
|
Labceutics
LONDON--(Marketwire - Jun 19, 2012) - Labceutics (www.labceutics.com), the leading personalized medicine laboratory network in the EU, has launched the Labceutics ConnectÔ platform. Labceutics...
Stellar Biotechnologies & Life Diagnostics Announce Agreement for Stellar Brand KLH ELISA Test Kits
October 26, 2011 09:15 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA and WEST CHESTER, PA--(Marketwire - Oct 26, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) and Life Diagnostics, Inc. are pleased to announce they...
Stellar Biotechnologies Announces a Strategic Agreement for Marketing and Sales With SAFC(R)
August 03, 2011 16:05 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Aug 3, 2011) - Stellar Biotechnologies, Inc. "Stellar" (TSX-V: KLH) (PINKSHEETS: SBOTF) is pleased to announce they have entered into an agreement for marketing and...